These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17415903)

  • 1. Biomarkers for prediction of cardiovascular events.
    Fletcher RH; Fletcher SW
    N Engl J Med; 2007 Apr; 356(14):1473; author reply 1474-5. PubMed ID: 17415903
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers for prediction of cardiovascular events.
    Mints G; Shah NR
    N Engl J Med; 2007 Apr; 356(14):1473-4; author reply 1474-5. PubMed ID: 17415904
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomarkers for prediction of cardiovascular events.
    Ridker PM; Cook NR
    N Engl J Med; 2007 Apr; 356(14):1472-3; author reply 1474-5. PubMed ID: 17415901
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarkers for prediction of cardiovascular events.
    Hauswald M
    N Engl J Med; 2007 Apr; 356(14):1474; author reply 1474-5. PubMed ID: 17415900
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers for prediction of cardiovascular events.
    Becker DM; Mora S; Goff DC
    N Engl J Med; 2007 Apr; 356(14):1473; author reply 1474-5. PubMed ID: 17415902
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers for prediction of cardiovascular events.
    Musunuru K; Blumenthal RS
    N Engl J Med; 2007 Apr; 356(14):1472; author reply 1474-5. PubMed ID: 17409333
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of risk prediction models in cardiovascular disease research.
    Cui J
    Ann Epidemiol; 2009 Oct; 19(10):711-7. PubMed ID: 19628409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk prediction: basic concepts, current status, and future directions.
    Lloyd-Jones DM
    Circulation; 2010 Apr; 121(15):1768-77. PubMed ID: 20404268
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W
    Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What are the biomarkers of atherosclerosis and cardiovascular risk?].
    Riesen WF
    Rev Med Suisse; 2008 Mar; 4(148):636-8, 640-3. PubMed ID: 18459658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide.
    McGeechan K; Macaskill P; Irwig L; Liew G; Wong TY
    Arch Intern Med; 2008 Nov; 168(21):2304-10. PubMed ID: 19029492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for cardiovascular risk assessment.
    Wolfert RL
    MLO Med Lab Obs; 2009 May; 41(5):14-6. PubMed ID: 19526891
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.
    Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST
    Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational prediction models for early detection of risk of cardiovascular events using mass spectrometry data.
    Pham TD; Wang H; Zhou X; Beck D; Brandl M; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Wong ST
    IEEE Trans Inf Technol Biomed; 2008 Sep; 12(5):636-43. PubMed ID: 18779078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence-based medicine and cardiovascular risk stratification aimed to drug reimbursement: uselessness of risk charts].
    Pujia A
    Ital Heart J Suppl; 2004 Aug; 5(8):661-3. PubMed ID: 15554022
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 19. Associations between migraine and cardiovascular disease.
    Kurth T
    Expert Rev Neurother; 2007 Sep; 7(9):1097-104. PubMed ID: 17868009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
    Carlquist JF; Muhlestein JB; Anderson JL
    Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.